Shots:

• Abbott and Sanofi team up to develop tools integrating their blood sugar tracking and insulin delivery technologies to help diabetes patients in managing their conditions
• The non-exclusive agreement will combine Abbott’s FreeStyle Libre continuous glucose monitoring system with Sanofi’s connected insulin pens- apps and cloud software currently in development- allowing patients & doctors to share data and to make better treatment decisions around medication- nutrition and lifestyle
• Abbott's FreeStyle Libre system is used to monitor the glucose level via sensor and is linked with an app that enables users to capture real-time glucose levels- their eight-hour glucose history- and how their glucose is currently changing on their smartphones

Click here to­ read full press release/ article

| Ref: Abbott | Image: Abbott